https://thescriptpad.com/articles/keynote-c93-trofuse-005-esmo-endometrial-cancer-pembrolizumab-sacituzumab-tirumotecan.htmlThe Script Paden2026-10-27T10:20:00-04:00Pembrolizumab Alone Beat Chemotherapy First Line in dMMR Endometrial Cancer. A New ADC Extended Survival After It. https://thescriptpad.com/articles/dellphi-305-tarlatamab-durvalumab-maintenance-small-cell-lung-cancer-overall-survival.htmlThe Script Paden2026-10-27T10:10:00-04:00Adding Tarlatamab to Durvalumab Maintenance Cut the Risk of Death 58 Percent in Extensive-Stage Small Cell Lung Cancer https://thescriptpad.com/articles/moio-trial-immunotherapy-every-12-weeks-stopped-early-survival.htmlThe Script Paden2026-10-27T10:00:00-04:00Spacing Immunotherapy to Every 12 Weeks Failed in the MOIO Trial. More Patients Died. https://thescriptpad.com/articles/dr-roscoe-nelson-normal-is-not-optimal.htmlThe Script Paden2026-10-26T21:00:00-04:00Dr. Roscoe Nelson Says Normal Is Not Optimal in Hormone Care https://thescriptpad.com/articles/krascendo-1-divarasib-kras-g12c-nsclc-overall-survival.htmlThe Script Paden2026-10-26T10:30:00-04:00Divarasib Beat Sotorasib and Adagrasib Head to Head in KRAS G12C Lung Cancer. Patients Also Lived Longer. https://thescriptpad.com/articles/idaho-proposition-1-abortion-ban-repeal-what-changes-for-physicians.htmlThe Script Paden2026-10-26T10:20:00-04:00Idaho Votes Nov. 3 on Repealing Its Abortion Ban. Here Is What Proposition 1 Would Change for Physicians. https://thescriptpad.com/articles/fda-approves-talazoparib-enzalutamide-hrr-metastatic-castration-sensitive-prostate-cancer.htmlThe Script Paden2026-10-26T10:15:00-04:00FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated Metastatic Castration-Sensitive Prostate Cancer https://thescriptpad.com/articles/hhs-kidney-care-national-plan-nephrologist-dialysis-ties-23-recommendations.htmlThe Script Paden2026-10-26T10:12:00-04:00HHS's Kidney Care Plan Targets Dialysis Chains and Nephrologist Ties. None of Its 23 Recommendations Has a Deadline. https://thescriptpad.com/articles/fda-approves-awiqli-insulin-icodec-pediatric-type-2-diabetes.htmlThe Script Paden2026-10-26T10:10:00-04:00FDA Approves Once-Weekly Insulin Icodec for Children With Type 2 Diabetes https://thescriptpad.com/articles/cms-9873-p-marketplace-pre-eligibility-verification-2028-subsidies.htmlThe Script Paden2026-10-26T10:00:00-04:00Marketplace Patients Would Have to Re-Verify Each Year to Keep Subsidies Starting in 2028 https://thescriptpad.com/articles/interpath-001-esmo-intismeran-pembrolizumab-melanoma-rfs-hr-058.htmlThe Script Paden2026-10-25T14:00:00-04:00Individualized mRNA Therapy Cut Melanoma Recurrence 42 Percent in Phase 3. The Benefit Started After Six Months. https://thescriptpad.com/articles/circadian-depression-subtype-bjp-23-percent-poorer-ssri-response.htmlThe Script Paden2026-10-25T13:50:00-04:00A Proposed Circadian Subtype of Depression Fit 23 Percent of Patients. They Reported Less Benefit From SSRIs. https://thescriptpad.com/articles/fda-approves-skyrizi-subcutaneous-induction-crohns-affirm.htmlThe Script Paden2026-10-25T13:40:00-04:00FDA Approves Subcutaneous Induction for Risankizumab in Crohn's Disease. The Label's TB Testing Language Also Changed. https://thescriptpad.com/articles/dr-sarfaraz-dhanji-took-insurance-out-of-the-exam-room.htmlThe Script Paden2026-10-25T12:00:00-04:00Why Dr. Sarfaraz Dhanji Took Insurance Out of the Exam Room